Variant report

Variant	esv3361165
Chromosome Location	chr6:12748791-12751339
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr6:12749410-12749743	H1-hESC	embryonic stem cell:	n/a	n/a
2	ATF2	chr6:12749240-12749753	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr6:12750132-12750384	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr6:12749326-12749695	H1-hESC	embryonic stem cell:	n/a	n/a
5	CEBPB	chr6:12749309-12749696	H1-hESC	embryonic stem cell:	n/a	n/a
6	CEBPB	chr6:12749398-12749544	HepG2	liver:	n/a	n/a
7	CEBPB	chr6:12749451-12749472	A549	lung:	n/a	n/a
8	CHD2	chr6:12749451-12749812	H1-hESC	embryonic stem cell:	n/a	chr6:12749529-12749539
9	CTBP2	chr6:12748829-12750689	H1-hESC	embryonic stem cell:	n/a	n/a
10	CTCF	chr6:12748820-12748970	HEK293	kidney:	n/a	n/a
11	CTCF	chr6:12749349-12749388	ProgFib	skin:	n/a	n/a
12	CTCF	chr6:12748780-12748930	WERI-Rb-1	eye:	n/a	n/a
13	CTCF	chr6:12749400-12749550	SK-N-SH_RA	brain:	n/a	chr6:12749524-12749537
14	CTCF	chr6:12748760-12749074	H1-hESC	embryonic stem cell:	n/a	n/a
15	E2F6	chr6:12749217-12749731	H1-hESC	embryonic stem cell:	n/a	chr6:12749603-12749613 chr6:12749428-12749436 chr6:12749428-12749438 chr6:12749430-12749445 chr6:12749353-12749362 chr6:12749429-12749436 chr6:12749429-12749437 chr6:12749428-12749439 chr6:12749429-12749440 chr6:12749533-12749542 chr6:12749429-12749437
16	EGR1	chr6:12749338-12749794	H1-hESC	embryonic stem cell:	n/a	chr6:12749353-12749363
17	EGR1	chr6:12749385-12749896	H1-hESC	embryonic stem cell:	n/a	n/a
18	EP300	chr6:12749370-12749756	H1-hESC	embryonic stem cell:	n/a	chr6:12749523-12749539
19	GATA2	chr6:12748846-12749679	SH-SY5Y	brain:	n/a	chr6:12749182-12749192 chr6:12749184-12749191 chr6:12749182-12749191 chr6:12749184-12749191 chr6:12749182-12749191 chr6:12749184-12749191
20	GTF2F1	chr6:12748836-12748910	H1-hESC	embryonic stem cell:	n/a	n/a
21	GTF2F1	chr6:12749492-12749771	H1-hESC	embryonic stem cell:	n/a	n/a
22	JUN	chr6:12749457-12749724	H1-hESC	embryonic stem cell:	n/a	chr6:12749532-12749541
23	JUND	chr6:12750212-12750359	H1-hESC	embryonic stem cell:	n/a	n/a
24	JUND	chr6:12749416-12749717	H1-hESC	embryonic stem cell:	n/a	chr6:12749532-12749541
25	JUND	chr6:12749403-12749727	H1-hESC	embryonic stem cell:	n/a	chr6:12749532-12749541
26	JUND	chr6:12749421-12749723	H1-hESC	embryonic stem cell:	n/a	chr6:12749532-12749541
27	MAFK	chr6:12749276-12749733	H1-hESC	embryonic stem cell:	n/a	chr6:12749444-12749459 chr6:12749447-12749463 chr6:12749445-12749465 chr6:12749448-12749462
28	MAFK	chr6:12748677-12749007	H1-hESC	embryonic stem cell:	n/a	n/a
29	MAFK	chr6:12749332-12749531	HepG2	liver:	n/a	chr6:12749444-12749459 chr6:12749447-12749463 chr6:12749445-12749465 chr6:12749448-12749462
30	MAFK	chr6:12749374-12749519	HepG2	liver:	n/a	chr6:12749444-12749459 chr6:12749447-12749463 chr6:12749445-12749465 chr6:12749448-12749462
31	MAX	chr6:12749781-12750687	H1-hESC	embryonic stem cell:	n/a	chr6:12750472-12750482
32	MAX	chr6:12749227-12750659	H1-hESC	embryonic stem cell:	n/a	chr6:12750472-12750482
33	MXI1	chr6:12750113-12750555	H1-hESC	embryonic stem cell:	n/a	n/a
34	MXI1	chr6:12748447-12750926	SK-N-SH	brain:	n/a	n/a
35	MYC	chr6:12750345-12750647	H1-hESC	embryonic stem cell:	n/a	chr6:12750472-12750482
36	MYC	chr6:12749500-12749734	H1-hESC	embryonic stem cell:	n/a	n/a
37	NANOG	chr6:12748547-12748929	H1-hESC	embryonic stem cell:	n/a	n/a
38	NRF1	chr6:12750102-12750742	SK-N-SH	brain:	n/a	chr6:12750337-12750346 chr6:12750474-12750483 chr6:12750339-12750348
39	NRF1	chr6:12750153-12750470	H1-hESC	embryonic stem cell:	n/a	chr6:12750337-12750346 chr6:12750339-12750348
40	POLR2A	chr6:12749326-12749559	ProgFib	skin:	n/a	n/a
41	POLR2A	chr6:12750135-12750283	H1-hESC	embryonic stem cell:	n/a	n/a
42	POLR2A	chr6:12749306-12749586	H1-hESC	embryonic stem cell:	n/a	n/a
43	POLR2A	chr6:12749806-12750048	H1-hESC	embryonic stem cell:	n/a	n/a
44	POLR2A	chr6:12749322-12749652	H1-hESC	embryonic stem cell:	n/a	n/a
45	POLR2A	chr6:12749301-12749600	H1-hESC	embryonic stem cell:	n/a	n/a
46	POLR2A	chr6:12749194-12750748	H1-neurons	neurons:	n/a	n/a
47	POLR2A	chr6:12750289-12750585	H1-hESC	embryonic stem cell:	n/a	n/a
48	POLR2A	chr6:12749773-12750735	H1-neurons	neurons:	n/a	n/a
49	POLR2A	chr6:12749821-12749968	H1-hESC	embryonic stem cell:	n/a	n/a
50	RAD21	chr6:12750122-12750627	H1-hESC	embryonic stem cell:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:12750030-12750080	HEK293	kidney:	embryo
2	chr6:12750256-12750306	IMR90	lung:	fetal
3	chr6:12750256-12750306	CMK	blood:	n/a
4	chr6:12750030-12750080	MCF10A-Er-Src	breast:	n/a
5	chr6:12750030-12750080	Hela-S3	cervix:	n/a
6	chr6:12750256-12750306	AG10803	skin:	n/a
7	chr6:12749567-12749617	IMR90	lung:	fetal
8	chr6:12749567-12749617	BJ	skin:	n/a
9	chr6:12749567-12749617	HCM	heart:	n/a
10	chr6:12749352-12749402	HNPCEpiC	eye:	n/a
11	chr6:12749352-12749402	LNCaP	prostate:	n/a
12	chr6:12750256-12750306	AoSMC	blood vessel:	n/a
13	chr6:12749352-12749402	GM06990	blood:	n/a
14	chr6:12749567-12749617	HMEC	breast:	n/a
15	chr6:12749978-12750028	BE2_C	brain:	n/a
16	chr6:12750256-12750306	K562	blood:	n/a
17	chr6:12749567-12749617	NH-A	brain:	n/a
18	chr6:12749567-12749617	CMK	blood:	n/a
19	chr6:12749567-12749617	GM12891	blood:	n/a
20	chr6:12749567-12749617	Hela-S3	cervix:	n/a
21	chr6:12750030-12750080	HRE	kidney:	n/a
22	chr6:12750256-12750306	AG04449	skin:	fetal
23	chr6:12750392-12750442	AG10803	skin:	n/a
24	chr6:12749567-12749617	HCF	heart:	n/a
25	chr6:12749352-12749402	A549	lung:	n/a
26	chr6:12750030-12750080	HMEC	breast:	n/a
27	chr6:12749567-12749617	SKMC	muscle:	n/a
28	chr6:12750392-12750442	BJ	skin:	n/a
29	chr6:12749352-12749402	ProgFib	skin:	n/a
30	chr6:12749567-12749617	ECC-1	luminal epithelium:	n/a
31	chr6:12749352-12749402	GM12892	blood:	n/a
32	chr6:12750030-12750080	AG09319	gingival:	n/a
33	chr6:12750030-12750080	A549	lung:	n/a
34	chr6:12749567-12749617	ovcar-3	ovarian:	n/a
35	chr6:12749978-12750028	NHBE	bronchial:	n/a
36	chr6:12749978-12750028	GM12892	blood:	n/a
37	chr6:12750030-12750080	HIPEpiC	eye:	n/a
38	chr6:12749352-12749402	PrEC	prostate:	n/a
39	chr6:12750030-12750080	BE2_C	brain:	n/a
40	chr6:12749978-12750028	ProgFib	skin:	n/a
41	chr6:12749978-12750028	PFSK-1	brain:	n/a
42	chr6:12750030-12750080	Jurkat	blood:	n/a
43	chr6:12750392-12750442	HCT-116	colon:	n/a
44	chr6:12750256-12750306	HIPEpiC	eye:	n/a
45	chr6:12749567-12749617	HIPEpiC	eye:	n/a
46	chr6:12749567-12749617	HL-60	blood:	n/a
47	chr6:12750392-12750442	SK-N-MC	brain:	n/a
48	chr6:12750030-12750080	GM12891	blood:	n/a
49	chr6:12749352-12749402	HUVEC	blood vessel:	n/a
50	chr6:12749352-12749402	HIPEpiC	eye:	n/a

Variant related genes	Relation type
ENSG00000223291	TF binding region
PHACTR1	TF binding region
ENSG00000223291	CpG island
PHACTR1	CpG island

Extended variants
information (count: 85 )
Associated
traits (count: 99 )

Variant overlapped rSNPs/rCNVs (count:85 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs531013539	chr6:12748803-12748804	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs951191	chr6:12748825-12748826	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs527463309	chr6:12748863-12748864	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs140314339	chr6:12748956-12748957	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
5	rs567398533	chr6:12748975-12748976	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
6	rs530081047	chr6:12749036-12749037	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
7	rs369693245	chr6:12749069-12749070	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
8	rs78881041	chr6:12749125-12749126	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
9	rs569671071	chr6:12749140-12749141	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
10	rs538950101	chr6:12749174-12749175	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
11	rs558957391	chr6:12749217-12749218	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
12	rs566277438	chr6:12749270-12749271	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
13	rs9381384	chr6:12749356-12749357	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs553880599	chr6:12749371-12749372	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
15	rs142040768	chr6:12749420-12749421	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
16	rs536313291	chr6:12749425-12749426	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
17	rs556200624	chr6:12749449-12749450	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
18	rs373166119	chr6:12749467-12749468	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
19	rs73722816	chr6:12749485-12749486	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs116572618	chr6:12749493-12749494	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
21	rs151171008	chr6:12749523-12749524	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
22	rs540862484	chr6:12749533-12749534	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
23	rs561084039	chr6:12749565-12749566	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
24	rs530139685	chr6:12749610-12749611	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
25	rs557984606	chr6:12749618-12749619	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs13203845	chr6:12749628-12749629	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
27	rs549816846	chr6:12749636-12749637	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
28	rs577940408	chr6:12749716-12749717	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs563362766	chr6:12749726-12749727	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs532368291	chr6:12749773-12749774	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs543431342	chr6:12749786-12749787	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs552867040	chr6:12749827-12749828	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs368875405	chr6:12749916-12749917	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs199546311	chr6:12749973-12749974	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs535263200	chr6:12749990-12749991	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
36	rs373807800	chr6:12749994-12749995	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
37	rs200383533	chr6:12750013-12750014	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
38	rs367654764	chr6:12750041-12750042	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
39	rs371748587	chr6:12750056-12750057	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
40	rs80085591	chr6:12750060-12750061	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
41	rs536376919	chr6:12750112-12750113	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs373759527	chr6:12750113-12750114	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs576142354	chr6:12750167-12750168	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs538237030	chr6:12750217-12750218	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs558857465	chr6:12750222-12750223	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs561375625	chr6:12750231-12750232	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs572236020	chr6:12750268-12750269	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
48	rs541277051	chr6:12750294-12750295	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
49	rs560748568	chr6:12750329-12750330	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs574265091	chr6:12750352-12750353	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:99)

Disease	PMID	Source
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Cancer	20164920	CNVD
Colorectal cancer	21297112	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Multiple myeloma	17550852	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
small cell lung cancer	20016488	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Osteosarcoma	16790693	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Ovarian cancer	21720365	CNVD
Cancer	21183584	CNVD
Acute myeloid leukemia	18000384	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21364760	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Bladder cancer	21909424	CNVD
Myelofibrosis	22110671	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Burkitt''s lymphoma	19759907	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Metastatic melanoma	18483359	CNVD
Breast cancer	21990379	CNVD

Chromatin state (count:194 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:12748200-12748800	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
2	chr6:12748200-12749200	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
3	chr6:12748400-12748800	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
4	chr6:12748400-12749000	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
5	chr6:12748600-12748800	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
6	chr6:12748600-12748800	Flanking Active TSS	H1 Cell Line	embryonic stem cell
7	chr6:12748600-12748800	Flanking Active TSS	H9 Cell Line	embryonic stem cell
8	chr6:12748600-12748800	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
9	chr6:12748600-12748800	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
10	chr6:12748600-12749000	Active TSS	ES-I3 Cell Line	embryonic stem cell
11	chr6:12748600-12749400	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
12	chr6:12748800-12749000	Active TSS	iPS-18 Cell Line	embryonic stem cell
13	chr6:12748800-12749000	Bivalent/Poised TSS	Ganglion Eminence derived primary cultured neurospheres	brain
14	chr6:12748800-12749000	Enhancers	Brain Germinal Matrix	brain
15	chr6:12748800-12750400	Active TSS	ES-WA7 Cell Line	embryonic stem cell
16	chr6:12748800-12750600	Active TSS	H1 Cell Line	embryonic stem cell
17	chr6:12748800-12750600	Active TSS	HUES48 Cell Line	embryonic stem cell
18	chr6:12748800-12750600	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
19	chr6:12748800-12750600	Active TSS	iPS-20b Cell Line	embryonic stem cell
20	chr6:12748800-12751000	Active TSS	H9 Cell Line	embryonic stem cell
21	chr6:12748800-12752600	Active TSS	Fetal Brain Female	brain
22	chr6:12749000-12749200	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
23	chr6:12749000-12749200	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
24	chr6:12749000-12749200	Bivalent/Poised TSS	Cortex derived primary cultured neurospheres	brain
25	chr6:12749000-12749200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
26	chr6:12749000-12749200	Active TSS	Brain Inferior Temporal Lobe	brain
27	chr6:12749000-12749400	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
28	chr6:12749000-12749400	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
29	chr6:12749000-12749400	Flanking Active TSS	Brain Germinal Matrix	brain
30	chr6:12749000-12749600	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
31	chr6:12749000-12750400	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
32	chr6:12749000-12750400	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
33	chr6:12749000-12750600	Active TSS	HSMM	muscle
34	chr6:12749000-12750800	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
35	chr6:12749000-12751000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
36	chr6:12749000-12751000	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
37	chr6:12749200-12749400	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
38	chr6:12749200-12749400	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
39	chr6:12749200-12749400	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
40	chr6:12749200-12749400	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
41	chr6:12749200-12749400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
42	chr6:12749200-12749400	Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
43	chr6:12749200-12749400	Bivalent/Poised TSS	Brain Cingulate Gyrus	brain
44	chr6:12749200-12749400	Flanking Bivalent TSS/Enh	Brain Dorsolateral Prefrontal Cortex	brain
45	chr6:12749200-12749400	Bivalent Enhancer	Brain Substantia Nigra	brain
46	chr6:12749200-12749400	Bivalent Enhancer	Lung	lung
47	chr6:12749200-12749400	Flanking Bivalent TSS/Enh	Right Ventricle	heart
48	chr6:12749200-12749400	Bivalent/Poised TSS	Stomach Smooth Muscle	stomach
49	chr6:12749200-12749600	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells	blood
50	chr6:12749200-12749600	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links